Stock EMMLD OKYO PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart OKYO Pharma Limited

Equities

EMMLD

GG00BMFG5F62

Delayed Nasdaq
Other stock markets
 01:51:06 2024-06-20 pm EDT 		5-day change 1st Jan Change
1.245 USD -2.73% Intraday chart for OKYO Pharma Limited -8.46% -29.66%
Mar. 22 H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating MT
Mar. 22 OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
OKYO PHARMA LIMITED
Biopharmaceuticals
-2.73%-8.46%-29.66%+5.51%-79.84% 42.54M - - -
  1. Stock Market
  2. Equities
  3. EMMLD Stock
  4. Charts OKYO Pharma Limited
  5. Relative Strength Chart